See All Slides - tctmd.com

Slides

Presentation TCT 2015

My Most Unforgettable Structural Complication for 2015

Presenter: Paul S. Teirstein, Michael J. Mullen

October 15, 2015

Presentation TCT 2015

New Noninvasive Methods for Assessing Valvular Heart Disease

Presenter: Jeroen J. Bax, Paul A. Grayburn

October 15, 2015

Presentation TCT 2015

Things to Do in Your First 5 Years to Grow Your Career

Presenter: Manish A. Parikh, Sahil A. Parikh

October 15, 2015

Presentation TCT 2015

Case 5: Double the Mechanical Valves, Double the Paravalvular Leaks

Presenter: Chet Rihal, Eulogio J. Garcia

October 15, 2015

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

Presenter: Somjot S. Brar, Richard Solomon

October 15, 2015

Presentation TCT 2015

Debate 2: BVS Is a Revolutionary Breakthrough, Not an Expensive Gimmick. I'm Against the Proposal!

Presenter: Andreas Baumbach, Simon Redwood, Adrian P. Banning

October 15, 2015

Presentation TCT 2015

OCT to Solve a PCI Nightmare

Presenter: Takashi Akasaka, Giulio Guagliumi

October 15, 2015

Presentation TCT 2015

Case 4: Aortic Paravalvular Leak Closure After TAVR

Presenter: Chet Rihal, Peter M. Pollak

October 15, 2015

Presentation TCT 2015

TCT 112: Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention The REsponsiveness To CLOpidogrel And StEnt Thrombosis (RECLOSE) 3 Study

Presenter: Steven R. Bailey, Patrick W. Serruys, Renato Valenti

October 15, 2015

Presentation TCT 2015

Convince Me in 5 Minutes or Less That: Contrast Nephropathy Risk in TAVR Is Important!

Presenter: Somjot S. Brar, Richard Solomon, Philippe Généreux

October 15, 2015

Advertisement

Slides

My Most Unforgettable Structural Complication for 2015

New Noninvasive Methods for Assessing Valvular Heart Disease

Things to Do in Your First 5 Years to Grow Your Career

Case 5: Double the Mechanical Valves, Double the Paravalvular Leaks

Convince Me in 5 Minutes or Less That: Intravenous and Not Oral Hydration Is the Cornerstone for Contrast Nephropathy Prevention!

Debate 2: BVS Is a Revolutionary Breakthrough, Not an Expensive Gimmick. I'm Against the Proposal!

OCT to Solve a PCI Nightmare

Case 4: Aortic Paravalvular Leak Closure After TAVR

TCT 112: Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention The REsponsiveness To CLOpidogrel And StEnt Thrombosis (RECLOSE) 3 Study

Convince Me in 5 Minutes or Less That: Contrast Nephropathy Risk in TAVR Is Important!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content